Pancreatic Cancer-Associated Diabetes Mellitus: Prevalence and Temporal Association With Diagnosis of Cancer

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 95-101

  Chari, Suresh T ^a   Leibson, Cynthia L ^a   Rabe, Kari G ^a   Timmons, Lawrence J ^a   Ransom, Jeanine ^a   de Andrade, Mariza ^a   Petersen, Gloria M ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CONTROL GROUP; CONTROLLED STUDY; CRITERION VARIABLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 37349014799     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.10.040     Document Type: Article

References (36)

1. Wang F., Herrington M., Larsson J., et al. The relationship between diabetes and pancreatic cancer. Mol Cancer 2 (2003) 4
2. Huxley R., Ansary-Moghaddam A., Berrington de Gonzalez A., et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92 (2005) 2076-2083
3. Chari S., Leibson C.L., de Andrade M., et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129 (2005) 504-511
4. Rousseau M.C., Parent M.E., Pollak M.N., et al. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 118 (2006) 2105-2109
5. Gupta S., Vittinghoff E., Bertenthal D., et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 4 (2006) 1301 1366-1372
6. Wang F., Gupta S., and Holly E.A. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 15 (2006) 1458-1463
7. Noy A., and Bilezikian J.P. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab 79 (1994) 1223-1231
8. Ogawa Y., Tanaka M., Inoue K., et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer 94 (2002) 2344-2349
9. Damiano J., Bordier L., Le Berre J.P., et al. Should pancreas imaging be recommended in patients over 50 years when diabetes is discovered because of acute symptoms?. Diabet Metab 30 (2004) 203-207
10. Martinez A., Weaver C., Lopez J., et al. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 137 (1996) 2626-2632
11. Pannala R.L.J., Bamlet W.R., Basu A., et al. Very high prevalence of new-onset diabetes and impaired fasting glucose in pancreatic cancer-results of a case-control study. Gastroenterology 132 (2007) A118
12. Chari S.T., Klee G.G., Miller L.J., et al. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 121 (2001) 640-645
13. Permert J., Larsson J., Fruin A.B., et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 15 (1997) 60-68
14. Cersosimo E., Pisters P.W., Pesola G., et al. Insulin secretion and action in patients with pancreatic cancer. Cancer 67 (1991) 486-493
15. Permert J., Ihse I., Jorfeldt L., et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159 (1993) 101-107
16. Must A., Spadano J., Coakley E.H., et al. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
17. Legro R.S., Kunselman A.R., Dodson W.C., et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
18. Coustan D.R., Nelson C., Carpenter M.W., et al. Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol 73 (1989) 557-561
19. Harris M.I., Klein R., Welborn T.A., et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15 (1992) 815-819
20. Everhart J., and Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta- analysis. JAMA 273 (1995) 1605-1609
21. Gold E.B., Gordis L., Diener M.D., et al. Diet and other risk factors for cancer of the pancreas. Cancer 55 (1985) 460-467
22. Bueno de Mesquita H.B., Maisonneuve P., Moerman C.J., et al. Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer 52 (1992) 17-23
23. Cuzick J., and Babiker A.G. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer 43 (1989) 415-421
24. Jain M., Howe G.R., St Louis P., et al. Coffee and alcohol as determinants of risk of pancreas cancer: a case-control study from Toronto. Int J Cancer 47 (1991) 384-389
25. Lin R.S., and Kessler I.I. A multifactorial model for pancreatic cancer in man. Epidemiologic evidence. JAMA 245 (1981) 147-152
26. Norell S., Ahlbom A., Erwald R., et al. Diabetes, gall stone disease, and pancreatic cancer. Br J Cancer 54 (1986) 377-378
27. Silverman D.T., Schiffman M., Everhart J., et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80 (1999) 1830-1837
28. SEER. Fast Stats Pancreas Cancer. http://seer.cancer.gov/faststats Accessed on November 19th, 2007
29. Chari S.T. Detecting pancreatic cancer early: problems and prospects. Semin Oncol 34 (2007) 284-294
30. Permert J., Ihse I., Jorfeldt L., et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80 (1993) 1047-1050
31. Fogar P., Pasquali C., Basso D., et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 14 (1994) 2827-2830
32. Basso D., Brigato L., Veronesi A., et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res 15 (1995) 2585-2588
33. Basso D., Valerio A., Brigato L., et al. An unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes. Pancreas 15 (1997) 132-138
34. Basso D., Millino C., Greco E., et al. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes. Gut 53 (2004) 1159-1166
35. Li J., and Adrian T.E. A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myoblasts. Biochem Biophys Res Commun 260 (1999) 626-633
36. Wang F., Larsson J., Abdiu A., et al. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol 21 (1997) 157-164